# Repeat Immunoadsorption Post Covid ME/CFS

> **NCT05629988** · — · COMPLETED · sponsor: **Charite University, Berlin, Germany** · enrollment: 20 (actual)

## Conditions studied

- Post-COVID ME/CFS

## Interventions

- **DEVICE:** IA with TheraSorb ® column

## Key facts

- **NCT ID:** NCT05629988
- **Lead sponsor:** Charite University, Berlin, Germany
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2022-08-28
- **Primary completion:** 2025-02-11
- **Final completion:** 2025-03-31
- **Target enrollment:** 20 (ACTUAL)
- **Last updated:** 2025-05-31


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05629988

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05629988, "Repeat Immunoadsorption Post Covid ME/CFS". Retrieved via AI Analytics 2026-07-17 from https://api.ai-analytics.org/clinical/NCT05629988. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*
